ROBERTS EIRY
SEC insider (Form 3/4/5 filer). CIK 0001727606. Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX) and 2 other issuers. 21 reported Form 4/5 transactions since Sep 2024; latest on May 22, 2026. Located in SAN DIEGO, CA.
Companies ROBERTS EIRY has filed insider reports for
- NEUROCRINE BIOSCIENCES INC (NBIX): Officer, Chief Medical Officer
- Bausch Health Companies Inc. (BHC): Director
- AMICUS THERAPEUTICS, INC. (FOLD): Director
ROBERTS EIRY
CIK: 0001727606
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (21 total)
- May 22, 2026BHC
Bausch Health Companies Inc.
AwardDirect45.9K shares- - Apr 27, 2026FOLD
AMICUS THERAPEUTICS, INC.
DispositionDirect76.3K shares at avg. $14.50$1.1M - Jun 5, 2025FOLD
AMICUS THERAPEUTICS, INC.
AwardDirect20.4K shares- - Feb 14, 2025NBIX
NEUROCRINE BIOSCIENCES INC
SaleDirect500 shares at avg. $115.04$58K - Feb 13, 2025NBIX
NEUROCRINE BIOSCIENCES INC
SaleDirect604 shares at avg. $116.74$71K - Feb 13, 2025NBIX
NEUROCRINE BIOSCIENCES INC
ExerciseDirect1.4K shares- - Feb 13, 2025NBIX
NEUROCRINE BIOSCIENCES INC
ExerciseDirect2.1K shares- - Feb 13, 2025NBIX
NEUROCRINE BIOSCIENCES INC
ExerciseDirect1.1K shares- - Feb 13, 2025NBIX
NEUROCRINE BIOSCIENCES INC
SaleDirect1.1K shares at avg. $116.90$130K - Feb 12, 2025NBIX
NEUROCRINE BIOSCIENCES INC
AwardDirectStock Option
43.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 22, 2026 |  BHC Bausch Health Companies Inc. | Award | 45,871 | - | $0 | Direct |
| Apr 27, 2026 |  FOLD AMICUS THERAPEUTICS, INC. | Disposition | 76,275 | $14.50 | $1,105,988 | Direct |
| Jun 5, 2025 | FOLD AMICUS THERAPEUTICS, INC. | Award | 20,414 | - | - | Direct |
| Feb 14, 2025 |  NBIX NEUROCRINE BIOSCIENCES INC | Sale | 500 | $115.04 | $57,521 | Direct |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Sale | 604 | $116.74 | $70,510 | Direct |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise | 1,372 | - | - | Direct |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise | 2,113 | - | - | Direct |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise | 1,120 | - | - | Direct |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Sale | 1,114 | $116.90 | $130,232 | Direct |
| Feb 12, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Award Stock Option | 43,261 | - | - | Direct |
1-10 of 21 transactions